P falciparum resistance to antimalarial drugs is now widespread, and chloroquine - resistant P vivax is common in Papua New Guinea, Indonesia, and emerging in some other areas (eg, Southeast Asia, South Asia, the Middle East, East Africa, and the Americas) (2).